Earnings History Data for Traws Pharma, Inc. (TRAW) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Traws Pharma, Inc.
Traws Pharma Inc. is involved in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Traws Pharma Inc., formerly known as Onconova Therapeutics Inc., is based in NEWTOWN, Pa.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15-05-2024 | AH | TRAW | Traws Pharma, Inc. | 16.00 | -0.24 | -0.24 | 0.00 | Onconova Therapeutics GAAP EPS of -$0.24 beats by $0.01, revenue of $0.06M in-line [5/16/2024 1:07 PM] |
0.6584 | 0.0 (0.15%) |
0.66 | 0.0 (0.76%) |
0.55 - 1.33 | 48,290 | 50,000 | 1,977 | ||